January 3rd Biotech Update

A decent start to the trading of the year.  Are we looking a little toppy?  Perhaps.  I am not a fan of the sector not ending at the highs of the day.  We still were green but we were stronger earlier in the day than later.  I would not be stunned if the sector paused […]

January 2nd Biotech Update

A decent start to the new year.  We are near the highs for the sector and are setting up a potential breakout.  I am not sure that it happens this week but could very well happen with JPM related news starting later this week.  I know that JPM starts next week but sometimes companies like […]

December 28th Biotech Update

The sector remains strong.  It feels good to be talking about the continued strength longer than one would have expected.  I would still be cautious about new positions as the chart looks a little stretched.  I do not think we are anywhere near the end of this bull market, but all bull markets need time […]

December 27th Biotech Update

It has been one nice of a run for the sector and it looks almost straight up since the bottom.  This is a case of chasing and FOMO into the end of the year.  In the middle of November, I do not think anyone was saying we would be ending the year close to 52-week […]

December 26th Biotech Update

We are ending the year with a bang.  It looks like a lot of companies are wanting to get ahead of the JPM news cycle and are announcing deals pretty early.  I do wonder now what this means for the JPM hype cycle as it we now have had a good number of larger bolt […]

December 21st Biotech Update

Not the best day for the sector as trading slows down closer to the holidays.  I had been thinking we pullback further but even a 1% decline basically keeps us in this sideways range and then the afternoon happened.  It was not clear why the market suddenly decided to correct through price, but I was […]

December 19th Biotech Update

The sector has been holding up pretty well.  I have been in the camp that we are going to have a little correction via price in the near term (I think down to around the $81 level looks like solid support) but up to this point the correction have been through time (sideways trading as […]

December 18th Biotech Update

We have had quite the run the past couple of weeks.  I think news probably begins to slow as we approach the end of the year and as companies perhaps start saving news for JPM.  Obviously, there are limits as to how long you can sit on material news but companies do like to hit […]

December 14th Biotech Update

News is going to start slowing as we get closer to the holiday and new year.  That being said we are having some very nice momentum to end the year.  This is probably the strongest we have been for a long time.  It seems clear that rates have peaked, and the next move will be […]

December 11th Biotech Update

The sector has had a great run.  Positive news and increasing confidence that rates have topped were a nice combination.  I do think there is likely going to be a short-term pause to the move higher as the sector looks a bit overbought.  I would not be stunned to see a pullback to the $73-$75 […]

December 6th Biotech Update

The sector continues to look healthy into the end of the year.  I thought this might be a week of pullback but so far it looks more like a week of pause.  Both of these scenarios would be healthy but if we are pausing then it could take a little more time for the overbought […]

December 4th Biotech Update

It was a nice end to the week.  I suspect that we should have a little follow up but we are probably due for a pause sooner rather than later.  Although it might not feel like it but we are up 20%+ from the recent lows.  I am sure we all feel that the sector […]

December 1st Biotech Update

We the news that we needed to really push the sector higher with a large oncology deal.  Now the move is good to see and certainly adds some nice momentum to the sector but ideally we would want that to last a couple of days.  One day spike higher and then giving it back over […]

November 29th Biotech Update

Not the greatest start to the week but also not the worst.  No significant green bars but we also seem to have hit some area of support each day and rallied.  As long as that trend is maintained this is not a bad situation.  One could be looking at the development of support at these […]

November 27th Biotech Update

There is really not a lot to talk about.  The news coming out of the holiday is pretty slow.  I will keep this short as we continue to setup the end of the year.  It will be interesting to see what happens with the competing pressure in the sector with some tailwinds as rates seem […]

November 22nd Biotech Update

We are limping into holiday, which I do not read all that much into it.  Volumes and news are slow and as long as we end up above $72, I think we are in good shape.  The issue would be a low volume selloff that breaks this mini-trend we have established.  In that case, do […]

November 17th Biotech Update

I am going to keep this one short as there is not a ton of news, which is not surprising as we enter into the Thanksgiving holiday week.  I think we certainly have had a good week, even though I sort of feel that it could have been better.  The little loss of momentum yesterday […]

November 14th Biotech Update

Yesterday did not start the way we wanted but it certainly ended much better.  A red to green move down at the lower levels is a good sign that support is building.  The next part of the process (if we can start to build a bull case) would be a continuation of that momentum, which […]

November 13th Biotech Update

We had a nice little reversal on Friday and that could set us up well into this week.  We certainly need to build off of that move and have a solid week of green.  We had some nice solid news this weekend on the data front that could stimulate some more fundamental interest in the […]

November 10th Biotech Update

Kind of a bad way to end the week but is it?  The sector got hit with a double whammy of bad news plus Fed talk that was pretty hawkish on rates.  So the two biggest issues for the sector were brought to the forefront and it pummeled the sector once again.  I still think […]